ML22269A496
| ML22269A496 | |
| Person / Time | |
|---|---|
| Site: | 03039313 |
| Issue date: | 09/26/2022 |
| From: | Casey Alldredge NRC/RGN-IV/DRSS/MLB |
| To: | Document Control Desk |
| References | |
| License-631847-177833 | |
| Download: ML22269A496 (1) | |
See also: IR 05000356/1979001
Text
U.S. NUCLEAR REGULATORY COMMISSION
MATERIALS LICENSE
PAGE
OF
1
3
PAGES
Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I,
Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued
authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s)
and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This
license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and
orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below.
Licensee
Fairbanks, AK 99709
2. 1651 College Road
dba Aurora Animal Clinic
1. Aurora Animal Care, Inc.
4. Expiration Date: September 30, 2037
Docket No.:
5.
030-39313
License No.: 50-35679-01
Reference No.:
3.
In accordance with letter dated
April 28, 2022; application dated
May 03, 2022; and letter dated
September 20, 2022,
6.
7.
8.
Byproduct, source,
and/or special nuclear
material
Chemical and/or physical form
Maximum amount that licensee
may possess at any one time
under this license
9.
Authorized use
A.
A.
A.
A.
For use of Synovetin OA in veterinary
medicine for the treatment of
osteoarthritis in dogs.
Colloid
6 millicuries maximum per
procedure and 200
millicuries total
Tin-117m
License No.:
Docket or Reference No.:
U.S. NUCLEAR REGULATORY COMMISSION
MATERIALS LICENSE
SUPPLEMENTARY SHEET
PAGES
OF
PAGE
3
2
50-35679-01
030-39313
CONDITIONS
10. Licensed material shall be used or stored at the licensee's facilities located at: 1651 College Road, Fairbanks, Alaska, 99709
11.
The Radiation Safety Officer (RSO) for this license is Eric Hooper, MS.
12. Licensed material shall only be used by, or under the supervision of:
Authorized Users
Material and Use
Barbara Cole, DVM
SN117M; For veterinary therapy procedures
13. The licensee is authorized to hold radioactive material with a physical half-life of less than or equal to 120 days for decay-in-storage before
disposal in ordinary trash provided:
A.
Before disposal as ordinary trash, the waste shall be surveyed at the container surface with the appropriate survey instrument set on
its most sensitive scale and with no interposed shielding to determine that its radioactivity cannot be distinguished from background. All
radiation labels shall be removed or obliterated, except for radiation labels on materials that are within containers and that will be
managed as biomedical waste after they have been released from the licensee.
B.
A record of each such disposal permitted under this license condition shall be retained for 3 years. The record must include the date of
disposal, the date on which the byproduct material was placed in storage, the radionuclides disposed, the survey instrument used, the
background dose rate, the dose rate measured at the surface of each waste container, and the name of the individual who performed
the disposal.
14. The licensee shall not use the licensed material in or on humans.
15. Experimental animals, or the products from experimental animals, that have been administered licensed material shall not be used for
human or animal consumption.
License No.:
Docket or Reference No.:
U.S. NUCLEAR REGULATORY COMMISSION
MATERIALS LICENSE
SUPPLEMENTARY SHEET
PAGES
OF
PAGE
3
3
50-35679-01
030-39313
16. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements,
representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to
those statements, representations, and procedures that are required to be submitted in accordance with the regulations. The U.S. Nuclear
Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and
correspondence impose on the licensee requirements that are more restrictive than or in addition to the regulations.
A.
Application dated May 3, 2022 (ML22196A015)
B.
Letter dated August 11, 2022 (ML22266A103)
C. Letter dated September 20, 2022 (ML22266A099)
FOR THE U.S. NUCLEAR REGULATORY COMMISSION
By:
Date:
Region 4
September 26, 2022
Casey C.
Alldredge
Digitally signed by Casey C.
Alldredge
Date: 2022.09.26 13:33:42
-05'00'